1. Home
  2. LRMR vs ELLO Comparison

LRMR vs ELLO Comparison

Compare LRMR & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • ELLO
  • Stock Information
  • Founded
  • LRMR N/A
  • ELLO 1987
  • Country
  • LRMR United States
  • ELLO Israel
  • Employees
  • LRMR N/A
  • ELLO N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • ELLO Electric Utilities: Central
  • Sector
  • LRMR Health Care
  • ELLO Utilities
  • Exchange
  • LRMR Nasdaq
  • ELLO Nasdaq
  • Market Cap
  • LRMR 309.8M
  • ELLO 267.2M
  • IPO Year
  • LRMR N/A
  • ELLO 1995
  • Fundamental
  • Price
  • LRMR $4.10
  • ELLO $19.57
  • Analyst Decision
  • LRMR Strong Buy
  • ELLO
  • Analyst Count
  • LRMR 7
  • ELLO 0
  • Target Price
  • LRMR $16.71
  • ELLO N/A
  • AVG Volume (30 Days)
  • LRMR 5.0M
  • ELLO 2.8K
  • Earning Date
  • LRMR 11-14-2025
  • ELLO 09-30-2025
  • Dividend Yield
  • LRMR N/A
  • ELLO N/A
  • EPS Growth
  • LRMR N/A
  • ELLO N/A
  • EPS
  • LRMR N/A
  • ELLO N/A
  • Revenue
  • LRMR N/A
  • ELLO $48,322,959.00
  • Revenue This Year
  • LRMR N/A
  • ELLO N/A
  • Revenue Next Year
  • LRMR N/A
  • ELLO N/A
  • P/E Ratio
  • LRMR N/A
  • ELLO N/A
  • Revenue Growth
  • LRMR N/A
  • ELLO N/A
  • 52 Week Low
  • LRMR $1.61
  • ELLO $12.75
  • 52 Week High
  • LRMR $9.50
  • ELLO $23.69
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 47.65
  • ELLO 58.10
  • Support Level
  • LRMR $3.88
  • ELLO $17.64
  • Resistance Level
  • LRMR $4.53
  • ELLO $19.66
  • Average True Range (ATR)
  • LRMR 0.42
  • ELLO 1.09
  • MACD
  • LRMR -0.06
  • ELLO 0.05
  • Stochastic Oscillator
  • LRMR 51.10
  • ELLO 31.90

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About ELLO Ellomay Capital Ltd (Israel)

Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.

Share on Social Networks: